COX/LOX dual inhibitors (c-a-i-r biosciences)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCOX/LOX dual inhibitors (c-a-i-r biosciences)
Drug Alias NameCOX/5-LO inhibitors (Merckle)cyclooxygenase/5-lipoxygenase inhibitors (Merckle)5-LOX/COX inhibitors (c-a-i-r biosciences)COX-1/LOX inhibitors (Merckle)cyclooxygenase/5-lipoxygenase inhibitors (c-a-i-r biosciences)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitorsArachidonate 5-lipoxygenase inhibitors
TargetsArachidonate 5-lipoxygenaseCyclooxygenases
Therapy Area/IndicationsInflammationOsteoarthritisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerckle Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesC-A-I-R BiosciencesMerckle Gmbh
Active IndicationsN/A
Inactive IndicationsInflammationOsteoarthritisNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A